News & Press | AmbioPharm - Part 2

We are pleased to welcome Gary Hu to the AmbioPharm family!

May 15, 2023

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits

April 25, 2023

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production

March 28, 2023

AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

March 21, 2023

Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership

October 27, 2022

OKYO Pharma and AmbioPharm logos

OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm

August 30, 2022

Amytrx and AmbioPharm logos

Amytrx Therapeutics Partners With AmbioPharm to Expand the Potential of Its Breakthrough Leukocyte-Targeting Anti-Inflammatory Human Peptides

July 26, 2022

AmbioPharm and ONL Therapeutics logos

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study

July 12, 2022

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS